Log In
BCIQ
Print this Print this
 

Lymphocyte-activation gene 3 (LAG3) (CD223)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Lymphocyte-activation gene 3 (LAG3) (CD223)

BCIQ
Print ChartPrint this
2 - Cancer 3 - Cancer 2 - Cancer 1 - Autoimmune 1 - Transplant 2 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase II
Autoimmune

-

1

-

-

Cancer

2

2

3

2

Transplant

1

-

-

-




 Products Targeting Lymphocyte-activation gene 3 (LAG3) (CD223)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

13

$3,153.1M

$692.8M

$871.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today